Prediction of Pain After Total Knee Arthroplasty
Prospective Descriptive Study of Nociceptive and Psychological Prediction of Pain After Total Knee Arthroplasty (TKA)
1 other identifier
observational
60
1 country
1
Brief Summary
Despite improvements in treatment, a significant part of patients have severe pain following knee arthroplasty. Preoperative identification of high-risk patients would allow for an intensive individualized analgesic treatment pre- and postoperatively and thus potentially in reduced pain acute and chronically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 29, 2014
CompletedFirst Posted
Study publicly available on registry
October 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedSeptember 23, 2015
September 1, 2015
1 year
September 29, 2014
September 22, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Pain
Pain intensity on a NRS from 0 to 10 upon ambulation 24 hours following surgery
24 hours postoperatively
Secondary Outcomes (2)
Pain
48 hours postoperatively
Pain
From day 1 to day 14 following surgery
Eligibility Criteria
Patients with knee osteoarthritis referred for total knee arthroplasty.
You may qualify if:
- primary unilateral TKA
- caucasian
- years
- osteoarthritis
You may not qualify if:
- deficient written or spoken danish
- impairment from psychological og neurological disease
- expected discharged to rehabilitation facility
- anticoagulant therapy
- allergies to analgesic treatment
- hypertension (systolic \> 160 / diastolic \> 100)
- ASA class ≥ 4
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- Lundbeck Foundationcollaborator
Study Sites (1)
Gentofte Hospital
Hellerup, 2900, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellow
Study Record Dates
First Submitted
September 29, 2014
First Posted
October 2, 2014
Study Start
September 1, 2014
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
September 23, 2015
Record last verified: 2015-09